Please Wait.....
Report
Large Volume Parenteral (LVP) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-01-16 I 140 Pages I Mordor Intelligence
Large Volume Parenteral (LVP) Market Analysis
The large volume parenteral market size in 2026 is estimated at USD 9.32 billion, growing from 2025 value of USD 8.91 billion with 2031 projections showing USD 11.69 billion, growing at 4.62% CAGR over 2026-2031. Rising surgical case counts, an expanding chronic disease burden, and broader adoption of automated aseptic processing collectively underpin this stable trajectory. Demand also benefits from home-based infusion programs that shift IV therapy outside hospitals, while regulatory recognition of Blow-Fill-Seal (BFS) technology accelerates capacity expansion. Supply chain investments in polymer bags and pharmaceutical-grade water infrastructure continue to improve manufacturing resilience, even as glass vial shortages linger. Competitive strategies center on scale, vertical integration, and technology upgrades, indicating a structurally moderate but steadily evolving landscape for the large volume parenteral market.
Global Large Volume Parenteral (LVP) Market Trends and Insights
Rising Surgical Volumes Worldwide
Elective procedure throughput recovered sharply in 2024, exceeding 2019 baselines by 12% as hospitals addressed pandemic-era backlogs. Each surgical event typically consumes 2-4 L of IV fluids, increasing aggregate demand for the large volume parenteral market. Growing robotic surgery uptake-up 18% in 2024-extends operating times and thus elevates perioperative fluid requirements. An aging patient cohort intensifies this pattern because individuals over 65 often need additional volume for hemodynamic stability.
Growing Chronic Disease Prevalence & Fluid Replacement Therapy Adoption
Chronic kidney disease affects 850 million people, and dialysis protocols alone represent a USD 2.8 billion fluid segment. Heart failure reached 64 million global cases in 2024, spurring demand for specialized electrolyte solutions. The Centers for Disease Control and Prevention recorded a 23% rise in diabetes-related hospitalizations requiring IV therapy, where typical diabetic ketoacidosis care involves 6-8 L of fluids per episode.
Complex Formulation & Extractables-Leachables Compliance Challenges
FDA and USP updates released in 2024 force exhaustive analytical testing of container-closure systems, extending validation timelines to as long as 24 months and adding USD 2.8 million in compliance costs per product. Requirements to quantify extractables down to 0.15 g/day strain smaller firms and slow product introductions, tempering the growth of the large volume parenteral market.
Other drivers and restraints analyzed in the detailed report include:
Expansion of Home-Based Infusion & Parenteral Nutrition ProgramsAdoption of BFS & Other Automated Aseptic TechnologiesPrice Pressures & Reimbursement Caps in High-Volume Hospital Tenders
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
The >2,000 mL category will post a 9.08% CAGR through 2031, buoyed by oncology and critical-care protocols that demand continuous delivery for 24-48 hours. Manufacturing advances have shaved 18% off production costs for these ultra-large containers since 2024. Meanwhile, the 500-1,000 mL range retained 39.12% large volume parenteral market share in 2025, due to standardized intra-operative and emergency guidelines that specify this mid-sized format. Regulatory bodies favor larger units to minimize line changes, further anchoring growth. Smaller segments serve pediatric and outpatient needs and collectively add resilience by diversifying end-use profiles in the large volume parenteral market.
Therapeutic injections dominated 2025 revenues at 45.10%, covering antibiotics, chemotherapy agents, and specialty drugs that require dilution in large volumes for safe infusion. Nutritious formulations, however, are accelerating at a 9.88% CAGR on the back of expanded HPN coverage and longer shelf-life stability. Customized amino-acid and lipid blends now match patient-specific metabolic profiles, supporting premium price points that offset volume discounts elsewhere in the large volume parenteral market.
The Large Volume Parenteral Market Report is Segmented by Volume (100 ML - 250 ML, 250 ML - 500 ML, and More), Application (Therapeutic Injections, and More), Type of Packaging (Bottles, and Flexible Bags), Manufacturing Technology (Traditional Aseptic Fill-Finish and Blow-Fill-Seal (BFS)), End User (Hospitals and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America commanded 35.25% of 2025 revenues, anchored by high procedure counts, advanced reimbursement systems, and established regulatory pathways. Market leaders leverage dense distribution networks that secure timely deliveries to urban and rural facilities alike. Robust insurance coverage also cushions price pressures in the large volume parenteral market.
Asia-Pacific is the fastest-growing territory at 8.63% CAGR through 2031. India's Production Linked Incentive scheme injected more than USD 2 billion into sterile injectable facilities, lifting domestic output 25%. China slashed approval timelines by 40% in 2024, enabling local firms to capture share in both domestic and export channels. Aging populations in Japan and South Korea further amplify demand.
Europe retains a sizable footprint owing to stringent but harmonized EMA standards that streamline multi-country registrations. Sustainability mandates push hospitals toward recyclable polymer bags, giving European suppliers an early-adopter advantage in green packaging. Germany leads adoption of hybrid BFS lines, reinforcing the competitive position of the European large volume parenteral market.
Emerging regions in Latin America, the Middle East, and Africa report double-digit unit growth, albeit from small bases. Infrastructure upgrades, donor-funded health programs, and gradual regulatory modernization provide incremental tailwinds, but supply chain gaps persist.
List of Companies Covered in this Report:
Amanta Healthcare B. Braun BAG Healthcare GmbH Baxter Becton Dickinson & Co. Eurofarma Fresenius Grifols ICU Medical JW Life Science Kelun Pharma Otsuka Pharmaceutical Co. Pfizer Salius Pharma Taj Pharma Terumo Corp. Teva Pharmaceutical Industries Vifor Pharma Group
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Surgical Volumes Worldwide
4.2.2 Growing Chronic Disease Prevalence & Adoption of Fluid Replacement Therapies
4.2.3 Expansion of Home-Based Infusion & Parenteral Nutrition Programs
4.2.4 Adoption of Blow-Fill-Seal (BFS) & Other Automated Aseptic Technologies
4.2.5 Shift Toward Large-Volume Wearable/SC Injectors Reducing Hospital Time
4.2.6 Supply-Chain Investments In Water-For-Injection (WFI) & Ready-To-Use Multichamber Bags
4.3 Market Restraints
4.3.1 Complex Formulation & Extractables-Leachables (E&L) Compliance Challenges
4.3.2 Price Pressures & Reimbursement Caps in High-Volume Hospital Tenders
4.3.3 Glass-Packaging Shortages & Material Recall Risks
4.3.4 Emerging Shift of Some Biologics From IV to SC Reducing LVP Demand
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Volume
5.1.1 100 - 250 mL
5.1.2 250 - 500 mL
5.1.3 500 - 1,000 mL
5.1.4 1,000 - 2,000 mL
5.1.5 More Than 2,000 mL
5.2 By Application
5.2.1 Therapeutic Injections
5.2.2 Fluid-Balance Injections
5.2.3 Nutritious/Parenteral Nutrition Injections
5.3 By Type of Packaging
5.3.1 Bottles (Glass)
5.3.2 Flexible Bags (PVC, Non-PVC)
5.4 By Manufacturing Technology
5.4.1 Traditional Aseptic Fill-Finish
5.4.2 Blow-Fill-Seal (BFS)
5.5 By End User
5.5.1 Hospitals
5.5.2 Home-Care & Alternate Site Infusion
5.5.3 Ambulatory Surgical Centers
5.6 By Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Amanta Healthcare
6.3.2 B. Braun SE
6.3.3 BAG Healthcare GmbH
6.3.4 Baxter International
6.3.5 Becton Dickinson & Co.
6.3.6 Eurofarma
6.3.7 Fresenius Kabi AG
6.3.8 Grifols S.A.
6.3.9 ICU Medical Inc.
6.3.10 JW Life Science
6.3.11 Kelun Pharma
6.3.12 Otsuka Pharmaceutical Co.
6.3.13 Pfizer Inc.
6.3.14 Salius Pharma
6.3.15 Taj Pharma
6.3.16 Terumo Corp.
6.3.17 Teva Pharmaceutical Industries
6.3.18 Vifor Pharma Group
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security